Adma Biologics: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported a loss of $17.6 million in its fourth quarter.

The Ramsey, New Jersey-based company said it had a loss of 8 cents per share. Earnings, adjusted to extinguish debt, came to 4 cents per share.

The infectious disease drug developer posted revenue of $73.9 million in the period.

For the year, the company reported that its loss narrowed to $28.2 million, or 13 cents per share. Revenue was reported as $258.2 million.

Adma Biologics shares have climbed 19% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.38, a climb of 52% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMA at https://www.zacks.com/ap/ADMA

Advertisement

Recommended Stories